First-in-Class Drug Approved for IgA Nephropathy

(MedPage Today) -- The FDA granted accelerated approval to atacicept (Trutakna) to reduce proteinuria in adults with primary IgA nephropathy at risk for disease progression.
Data from ORIGIN 3 supported approval of the once-weekly self-administered...